Skip to main content
NCBI home page
The Yale Journal of Biology and Medicine logoLink to The Yale Journal of Biology and Medicine
. 1988 Mar-Apr;61(2):123–136.

Evolving conceptualizations of cocaine dependence.

F H Gawin 1, H D Kleber 1
PMCID: PMC2590292  PMID: 3043925

Abstract

Cocaine was considered incapable of producing dependence in 1980 but was proclaimed the "drug of greatest national public health concern" by 1984. Clinical consensus in 1980 held that cocaine did not produce a withdrawal syndrome, but recent clinical investigations demonstrate that cocaine produces unique abuse and withdrawal patterns that differ from other major abused drugs. Evolving pre-clinical research over the past two decades now suggests that chronic cocaine abuse produces neurophysiological alterations in specific central nervous system systems that regulate the capacity to experience pleasure. These evolving clinical and pre-clinical constructs have led to applications of promising experimental pharmacological treatments for cocaine abuse.

Full text

PDF
123

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anker A. L., Crowley T. J. Use of contingency contracts in specialty clinics for cocaine abuse. NIDA Res Monogr. 1982 Apr;41:452–459. [PubMed] [Google Scholar]
  2. Charney D. S., Menkes D. B., Heninger G. R. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression. Arch Gen Psychiatry. 1981 Oct;38(10):1160–1180. doi: 10.1001/archpsyc.1981.01780350094011. [DOI] [PubMed] [Google Scholar]
  3. Dackis C. A., Gold M. S. Bromocriptine as treatment of cocaine abuse. Lancet. 1985 May 18;1(8438):1151–1152. doi: 10.1016/s0140-6736(85)92448-1. [DOI] [PubMed] [Google Scholar]
  4. Dackis C. A., Gold M. S., Sweeney D. R. The physiology of cocaine craving and 'crashing'. Arch Gen Psychiatry. 1987 Mar;44(3):298–300. doi: 10.1001/archpsyc.1987.01800150122018. [DOI] [PubMed] [Google Scholar]
  5. Dackis C. A., Gold M. S., Sweeney D. R. The physiology of cocaine craving and 'crashing'. Arch Gen Psychiatry. 1987 Mar;44(3):298–300. doi: 10.1001/archpsyc.1987.01800150122018. [DOI] [PubMed] [Google Scholar]
  6. Gawin F. H., Kleber H. D. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations. Arch Gen Psychiatry. 1986 Feb;43(2):107–113. doi: 10.1001/archpsyc.1986.01800020013003. [DOI] [PubMed] [Google Scholar]
  7. Gawin F. H., Kleber H. D. Cocaine abuse treatment. Open pilot trial with desipramine and lithium carbonate. Arch Gen Psychiatry. 1984 Sep;41(9):903–909. doi: 10.1001/archpsyc.1984.01790200085011. [DOI] [PubMed] [Google Scholar]
  8. Gawin F. H., Kleber H. D. Cocaine use in a treatment: population: patterns and diagnostic distinctions. NIDA Res Monogr. 1985;61:182–192. [PubMed] [Google Scholar]
  9. Gawin F. H., Kleber H. D. Neuroendocrine findings in a chronic cocaine abusers: a preliminary report. Br J Psychiatry. 1985 Nov;147:569–573. doi: 10.1192/bjp.147.5.569. [DOI] [PubMed] [Google Scholar]
  10. Gawin F. H. Neuroleptic reduction of cocaine-induced paranoia but not euphoria? Psychopharmacology (Berl) 1986;90(1):142–143. doi: 10.1007/BF00172886. [DOI] [PubMed] [Google Scholar]
  11. Gawin F., Kleber H. Pharmacologic treatments of cocaine abuse. Psychiatr Clin North Am. 1986 Sep;9(3):573–583. [PubMed] [Google Scholar]
  12. Gawin F., Riordan C., Kleber H. Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report. Am J Drug Alcohol Abuse. 1985;11(3-4):193–197. doi: 10.3109/00952998509016861. [DOI] [PubMed] [Google Scholar]
  13. Giannini A. J., Malone D. A., Giannini M. C., Price W. A., Loiselle R. H. Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine. J Clin Pharmacol. 1986 Mar;26(3):211–214. doi: 10.1002/j.1552-4604.1986.tb02936.x. [DOI] [PubMed] [Google Scholar]
  14. Giannini A. J., Malone D. A., Loiselle R. H., Price W. A. Blunting of TSH response to TRH in chronic cocaine and phencyclidine abusers. J Clin Psychiatry. 1987 Jan;48(1):25–26. [PubMed] [Google Scholar]
  15. Johanson C. E. Assessment of the dependence potential of cocaine in animals. NIDA Res Monogr. 1984;50:54–71. [PubMed] [Google Scholar]
  16. Khantzian E. J. An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. Am J Psychiatry. 1983 Jun;140(6):784–785. doi: 10.1176/ajp.140.6.784. [DOI] [PubMed] [Google Scholar]
  17. Kleber H. D., Gawin F. H. Cocaine abuse: a review of current and experimental treatments. NIDA Res Monogr. 1984;50:111–129. [PubMed] [Google Scholar]
  18. Kleber H. D., Gawin F. H. The spectrum of cocaine abuse and its treatment. J Clin Psychiatry. 1984 Dec;45(12 Pt 2):18–23. [PubMed] [Google Scholar]
  19. Kokkinidis L., Zacharko R. M., Predy P. A. Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants. Pharmacol Biochem Behav. 1980 Sep;13(3):379–383. doi: 10.1016/0091-3057(80)90242-7. [DOI] [PubMed] [Google Scholar]
  20. Rounsaville B. J., Gawin F., Kleber H. Interpersonal psychotherapy adapted for ambulatory cocaine abusers. Am J Drug Alcohol Abuse. 1985;11(3-4):171–191. doi: 10.3109/00952998509016860. [DOI] [PubMed] [Google Scholar]
  21. Rounsaville B. J., Spitzer R. L., Williams J. B. Proposed changes in DSM-III substance use disorders: description and rationale. Am J Psychiatry. 1986 Apr;143(4):463–468. doi: 10.1176/ajp.143.4.463. [DOI] [PubMed] [Google Scholar]
  22. Rowbotham M. C., Jones R. T., Benowitz N. L., Jacob P., 3rd Trazodone-oral cocaine interactions. Arch Gen Psychiatry. 1984 Sep;41(9):895–899. doi: 10.1001/archpsyc.1984.01790200077010. [DOI] [PubMed] [Google Scholar]
  23. Simpson D. M., Annau Z. Behavioral withdrawal following several psychoactive drugs. Pharmacol Biochem Behav. 1977 Jul;7(1):59–64. doi: 10.1016/0091-3057(77)90011-9. [DOI] [PubMed] [Google Scholar]
  24. Spyraki C., Fibiger H. C., Phillips A. G. Cocaine-induced place preference conditioning: lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res. 1982 Dec 16;253(1-2):195–203. doi: 10.1016/0006-8993(82)90686-2. [DOI] [PubMed] [Google Scholar]
  25. Tennant F. S., Jr, Sagherian A. A. Double-blind comparison of amantadine and bromocriptine for ambulatory withdrawal from cocaine dependence. Arch Intern Med. 1987 Jan;147(1):109–112. [PubMed] [Google Scholar]
  26. Weiss R. D., Mirin S. M., Michael J. L., Sollogub A. C. Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse. 1986;12(1-2):17–29. doi: 10.3109/00952998609083740. [DOI] [PubMed] [Google Scholar]

Articles from The Yale Journal of Biology and Medicine are provided here courtesy of Yale Journal of Biology and Medicine

RESOURCES